Logo image of V3V.DE

FAMICORD AG (V3V.DE) Stock Price, Quote, News and Overview

FRA:V3V - Deutsche Boerse Ag - DE000A0BL849 - Common Stock - Currency: EUR

4.18  0 (0%)

V3V.DE Quote, Performance and Key Statistics

FAMICORD AG

FRA:V3V (2/25/2025, 7:00:00 PM)

4.18

0 (0%)

Sector
GICS SectorHealth Care
GICS IndustryHealth Care Providers & Services
GICS IndustryGroupHealth Care Equipment & Services
GICS SubIndustryHealth Care Services
Statistics
52 Week High5.9
52 Week Low3.69
Market Cap73.74M
Shares17.64M
Float5.36M
Yearly Dividend0.16
Dividend YieldN/A
PE29.86
Fwd PEN/A
Earnings (Next)04-30 2025-04-30/amc
IPO11-21 2007-11-21


V3V.DE short term performance overview.The bars show the price performance of V3V.DE in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 0 2 -2 -4 -6 -8

V3V.DE long term performance overview.The bars show the price performance of V3V.DE in the last 1, 2 and 3 years. 1 year 2 years 3 years -20 -40 -60

The current stock price of V3V.DE is 4.18 EUR. In the past month the price decreased by -0.95%. In the past year, price decreased by -16.4%.

FAMICORD AG / V3V Daily stock chart

V3V.DE Competitors/Peers

The largest stocks on the EU markets in the "Health Care Services" sub-industry
Full List
Symbol
Name
TA
FA
PE
Market Cap
1CVS.MI CVS HEALTH CORP 11.73 76.15B
CVS.DE CVS HEALTH CORP 11.67 75.81B
FME.DE FRESENIUS MEDICAL CARE AG 16.1 26.45B
FRE.DE FRESENIUS SE & CO KGAA 36.05 21.93B

About V3V.DE

Company Profile

V3V logo image Vita 34 AG engages in the collection, storage, and distribution of cells, tissues, blood, and blood components for the purpose of medical applications. The company is headquartered in Leipzig, Sachsen and currently employs 745 full-time employees. The company went IPO on 2007-11-21. The firm is involved in the long-term storage and processing of stem cells from human umbilical cord blood. The cells are collected during the child’s birth and can be used later in his or her life for the treatment of many diseases, such as anemia, diabetes, degenerative joint diseases, cancer, neurological deficits after brain injuries, cartilage damages and others. They also allow the growing of whole organs, such as the liver. On average, one out seven individuals, whose cells are stored, receives autologous stem cell transplant by the age of 70. The firm acts as a cord blood bank and is also engaged in research activities around regenerative medicine, including curing the consequences of strokes and heart attacks. The firm operates in Germany, Spain, and Denmark.

Company Info

FAMICORD AG

Deutscher Platz 5a

Leipzig SACHSEN DE

Employees: 758

Company Website: https://www.vita34.de/

Investor Relations: http://ir.vita34.de/en/

Phone: 49341487920

FAMICORD AG / V3V.DE FAQ

What is the stock price of FAMICORD AG today?

The current stock price of V3V.DE is 4.18 EUR.


What is the ticker symbol for FAMICORD AG stock?

The exchange symbol of FAMICORD AG is V3V and it is listed on the Deutsche Boerse Ag exchange.


On which exchange is V3V.DE stock listed?

V3V.DE stock is listed on the Deutsche Boerse Ag exchange.


What is the price forecast or stock price prediction for FAMICORD AG stock?

5 analysts have analysed V3V.DE and the average price target is 6.43 EUR. This implies a price increase of 53.73% is expected in the next year compared to the current price of 4.18. Check the FAMICORD AG stock analysts ratings, price target forecast and up-and down grades for more detailed information.


What is FAMICORD AG worth?

FAMICORD AG (V3V.DE) has a market capitalization of 73.74M EUR. This makes V3V.DE a Micro Cap stock.


How many employees does FAMICORD AG have?

FAMICORD AG (V3V.DE) currently has 758 employees.


What are the support and resistance levels for FAMICORD AG (V3V.DE) stock?

FAMICORD AG (V3V.DE) has a support level at 4.17 and a resistance level at 4.22. Check the full technical report for a detailed analysis of V3V.DE support and resistance levels.


Is FAMICORD AG (V3V.DE) expected to grow?

The Revenue of FAMICORD AG (V3V.DE) is expected to grow by 9.33% in the next year. Check the estimates tab for more information on the V3V.DE EPS, Sales, EBIT and EBITDA future analyst estimates.


Should I buy FAMICORD AG (V3V.DE) stock?

There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:


Does FAMICORD AG (V3V.DE) stock pay dividends?

V3V.DE does not pay a dividend.


When does FAMICORD AG (V3V.DE) report earnings?

FAMICORD AG (V3V.DE) will report earnings on 2025-04-30, after the market close.


What is the Price/Earnings (PE) ratio of FAMICORD AG (V3V.DE)?

The PE ratio for FAMICORD AG (V3V.DE) is 29.86. This is based on the reported non-GAAP earnings per share of 0.14 and the current share price of 4.18 EUR. Check the full fundamental report for a full analysis of the valuation metrics for V3V.DE.


V3V.DE Technical Analysis

ChartMill assigns a technical rating of 1 / 10 to V3V.DE. When comparing the yearly performance of all stocks, V3V.DE is a bad performer in the overall market: 88.01% of all stocks are doing better.


Chartmill TA Rating
Chartmill Setup Rating

V3V.DE Fundamental Analysis

ChartMill assigns a fundamental rating of 4 / 10 to V3V.DE. V3V.DE has a bad profitability rating. Also its financial health evaluation is rather negative.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

V3V.DE Financial Highlights

Over the last trailing twelve months V3V.DE reported a non-GAAP Earnings per Share(EPS) of 0.14. The EPS increased by 109.51% compared to the year before.


Industry RankSector Rank
PM (TTM) 3.2%
ROA 1.61%
ROE 10.63%
Debt/Equity 0.56
Chartmill High Growth Momentum
EPS Q2Q%160%
Sales Q2Q%8.91%
EPS 1Y (TTM)109.51%
Revenue 1Y (TTM)7.73%

V3V.DE Ownership and Analysts

ChartMill assigns a Buy % Consensus number of 84% to V3V.DE. The Buy consensus is the average rating of analysts ratings from 5 analysts.

For the next year, analysts expect an EPS growth of 58.33% and a revenue growth 9.33% for V3V.DE


Ownership
Inst Owners2.65%
Ins Owners58.45%
Short Float %N/A
Short RatioN/A
Analysts
Analysts84
Price Target6.43 (53.83%)
EPS Next Y58.33%
Revenue Next Year9.33%